复发/难治性实体瘤/血液系统恶性肿瘤的临床试验
总计1772个结果
-
Acrotech Biopharma Inc.Axis Clinicals Limited终止
-
ArQule, Inc. (a wholly owned subsidiary of Merck...完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
CASI Pharmaceuticals, Inc.完全的
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.可用的
-
Shandong UniversityJuventas Cell Therapy Ltd.未知
-
National Cancer Institute (NCI)招聘中
-
University of Colorado, DenverUniversity of Kentucky完全的
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Acrotech Biopharma Inc.Axis Clinicals Limited完全的
-
Eli Lilly and CompanyChildren's Oncology Group完全的
-
Antengene Therapeutics LimitedBristol-Myers Squibb招聘中
-
Shanghai Yuyao Biotech Co., Ltd.招聘中
-
Acrotech Biopharma Inc.Axis Clinicals Limited完全的
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' Consortium完全的
-
Novartis Pharmaceuticals完全的Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies美国
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection Biology未知
-
Immatics US, Inc.完全的
-
Kite, A Gilead Company邀请报名
-
The Affiliated People's Hospital of Ningbo UniversityUTC Therapeutics Inc.招聘中
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of Birmingham招聘中
-
Samsung Medical CenterMinistry of Health, Republic of Korea尚未招聘
-
Merck Sharp & Dohme LLCEisai Inc.主动,不招人复发或难治性实体瘤美国, 阿根廷, 澳大利亚, 比利时, 克罗地亚, 捷克语, 法国, 危地马拉, 匈牙利, 以色列, 意大利, 大韩民国, 新西兰, 秘鲁, 俄罗斯联邦, 塞尔维亚, 南非, 西班牙, 瑞典, 火鸡